Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...

Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn.

Lupin gains US FDA approval for Tolvaptan tablets in various dosages, marking a significant entry into the nephrology market. The tablets, bioequivalent to Otsuka's Jynarque, will be manufactured at ...

Sunshine Biopharma currently markets 70 generic prescription drugs in Canada ... The company is also progressing with its proprietary drug development program, which includes K1.1 mRNA for ...

Additionally, Cuban suggested that all pharmacies should be fully reimbursed for brand drugs and that the generic cost ratio ... It also directed the development of regulations aimed at reducing ...

The boss of AstraZeneca said Europe should increase spending on health treatment in line with recent commitments on defence.

Bristol-Myers Squibb (BMY) stock is down 11% year-to-date as the company navigates several looming patent cliffs. After a $13 ...

Twenty-seven drug makers have signed onto a deal to manufacture a generic version of molnupiravir ... Neither Merck nor its development partners will receive any royalties from the licenses ...

In our oncology focus month, Ryan McGuire takes a look at the impact of clinical development on cancer drug prices and the factors involved in the current improved success rate for cancer treatments.

Many of the competencies required of a drug information resident are specific to executive issues, such as the development and ... Proprietary and generic drug manufacturers are staffed with ...

The antibiotics market generated sales of US$42 billion in 2009 globally, representing 46% of sales of anti-infective agents (which also include antiviral drugs ... as generic versions of an ...